Top 50 Life Science VC Funds & Investors in Germany (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
9 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $850k–$31M |
|
Lima Ventures
VC Fund
|
5 | Turkey, Estonia, United Kingdom | Seed, Pre-Seed | Artificial Intelligence, Software, FinTech | $20k–$697k |
|
coparion
VC Fund
|
5 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
Good Seed Ventures
VC Fund
|
5 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $55k–$50M |
|
IFB Innovationsstarter
VC Fund
|
5 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $79k–$3M |
|
CPT Capital
VC Fund
|
4 | United States, Israel, United Kingdom | Seed, Series A, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Agronomics
VC Fund
|
4 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Grazia Equity
VC Fund
|
4 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Inflection
VC Fund
|
3 | United States, Germany, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Blockchain, Cryptocurrency, Software | $500k–$28M |
|
IBB Ventures
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$11M |
|
b.value AG
VC Fund
|
3 | Germany, Poland | Seed, Series A | Biotechnology, Manufacturing, Chemical | $541k–$39M |
|
Elevat3 Capital
VC Fund
|
3 | Germany, United Kingdom | Series A, Series B, Series D | E-Commerce, Life Science, Biotechnology | $45M–$165M |
|
Entrepreneurs First
VC Fund
|
3 | United Kingdom, United States, India | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $55k–$30M |
|
Lowercarbon Capital
VC Fund
|
3 | United States, United Kingdom, France | Seed, Series A, Series B | Renewable Energy, Energy, Biotechnology | $3M–$150M |
|
Merck
VC Fund
|
2 | United States, Germany, China | Grant, Seed, Series A | Biotechnology, Pharmaceutical, Medical | $25k–$84M |
|
Almaro Holding AG
VC Fund
|
2 | Germany | Seed | Video Games, Life Science, Therapeutics | $1.1M–$1.4M |
|
Catalpa Ventures Family Office
VC Fund
|
2 | Germany, Luxembourg, The Netherlands | Seed, Angel, Venture - Series Unknown | Software, Information Technology, B2B | $1.3M–$1.4M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$30M |
|
The LAO
VC Fund
|
2 | United States, Singapore, Switzerland | Seed, Series A, Venture - Series Unknown | Blockchain, Cryptocurrency, Software | $100k–$30M |
|
MediVentures
VC Fund
|
2 | Germany | Seed, Series A, Venture - Series Unknown | Wellness, Health Care, Biotechnology | $2.3M–$17M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Ananda Impact Ventures
VC Fund
|
2 | Germany, United Kingdom, Finland | Seed, Series A, Series B | Health Care, Software, Information Technology | $1.6M–$53M |
|
Boost VC
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Virtual Reality | $100k–$8.9M |
|
Shine Capital
VC Fund
|
2 | United States, Spain, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $3.5M–$71M |
|
Chemovator
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Software, Manufacturing, Advanced Materials | $975k–$3.7M |
|
EQT Group
VC Fund
|
2 | Germany | Series A | Life Science, Biotechnology, Food and Beverage | $50M–$50M |
|
Happiness Capital
VC Fund
|
2 | United States, Germany, United Kingdom | Series A, Seed, Series B | Biotechnology, Food and Beverage, Health Care | $2.2M–$61M |
|
1kx
VC Fund
|
2 | United States, Germany, Singapore | Seed, Series A, Venture - Series Unknown | Blockchain, Cryptocurrency, Software | $1.8M–$40M |
|
TechOne VC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed | Software, SaaS, Information Technology | $30k–$2.4M |
|
Lionheart Ventures
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Wellness | $25k–$50M |
|
Magnetic Capital
VC Fund
|
2 | Germany, United States, Canada | Seed, Pre-Seed, Series A | Software, Apps, FinTech | $1.2M–$35M |
|
Zee Prime Capital
VC Fund
|
2 | United States, United Kingdom, Singapore | Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $2M–$43M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
KfW
VC Fund
|
2 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
hiVC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $175k–$1.2M |
|
Die Brückenköpfe
VC Fund
|
2 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $2M–$17M |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Angel, Pre-Seed | Health Care, Medical Device, Medical | $1.5M–$1.5M |
|
Investitionsbank Berlin
VC Fund
|
2 | Germany, Canada | Grant, Seed, Series A | Software, Information Technology, Artificial Intelligence | $18k–$19M |
|
Signature Ventures
VC Fund
|
1 | United States, Germany, United Kingdom | Seed, Pre-Seed, Series A | Blockchain, Software, FinTech | $385k–$23M |
|
Idinvest Partners
VC Fund
|
1 | France, United States, Germany | Series B, Series A, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.9M–$66M |
|
ATHOS Service
VC Fund
|
1 | Germany | Series A, Series C | Railroad, Software, Biopharma | |
|
Redmile Group
VC Fund
|
1 | United States, United Kingdom, France | Series C, Series B, Post-IPO Equity | Biotechnology, Health Care, Therapeutics | $25M–$275M |
|
Project Flying Elephant
VC Fund
|
1 | Germany, France, United States | Seed, Angel, Convertible Note | Social Media, News, Apps | |
|
Firegroup Holding AG
VC Fund
|
1 | Germany | Pre-Seed | Video Games, Life Science, Therapeutics | |
|
Kindergarten Ventures
VC Fund
|
1 | United States, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Financial Services | |
|
Picus Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, FinTech, Software | |
|
Recharge Thematic Ventures
VC Fund
|
1 | United States, China, Brazil | Seed, Series A, Series B | FinTech, Financial Services, Health Care | |
|
TechVision Fund
VC Fund
|
1 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | |
| Access all 278 VC funds in Germany Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 713
- Round size: Seed $850k–$6.9M; Series A $3.1M–$31M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Coredinate — COREDINATE is a fully integrated, professional and innovative solution for security companies, maintenance companies and care providers that helps optimize your processes, help you maintain your quality, and help you satisfy your customers. Whether it's control system, tour planning, task management or event capture: COREDINATE security ,maintenance or maintenance automates all your daily tasks and optimizes monitoring
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed
- Geography: Turkey, Estonia, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $20k–$697k; Pre-Seed $50k–$100k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — heybooster is the creator of a platform for marketing analysis that aids e-commerce managers in finding chances for revenue growth and in making better choices. It provides clients with digital reporting, online meetings, online communication, an online project management system, and an online playbook that helps them discover problems, findpossibilities for revenue growth, and cut expenses.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 39
- Round size: Seed $55k–$7M; Series A $7.5M–$50M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 90
- Round size: Seed $365k–$3M; Grant $79k–$178k
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 63
- Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 48
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from ananimal, allowing consumers to have sustainable food.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Meatly — Good Dog Food creates cultivated meat for healthy pets and a healthy planet
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 85
- Round size: Seed $1.1M–$8.2M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
- XO Life — XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.
- Patronus Group — Rethinking elderly healthcare
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 107
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 45
- Round size: Seed $2M–$13M; Pre-Seed $500k–$4.3M; Venture - Series Unknown $5.4M–$28M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — raised $40M in 2022
Portfolio highlights
- Ubitium — Ubiquitous computing, universal RISC-V microprocessor
- Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
- Fabric Cryptography — Building towards a trustless future with custom chips for advanced cryptography.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 250
- Round size: Seed $1M–$4.6M; Series A $2.3M–$11M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $120M in 2022
Portfolio highlights
- KAZIMI — KAZIMI is a cybersecurity startup that helps app developers protect and verify their first-party data.
- Nenna AI — Nenna AI is a powerful AI enablement platform designed for the secure application of AI technologies.
- Jurafuchs — Jurafuchs provides legal education via a mobile app.
b.value AG are into Biotechnology investments.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Chemical
- Stage:Seed, Series A
- Geography: Germany, Poland
Investor stats
- Total investments: 14
- Round size: Seed $541k–$2.5M; Series A $3M–$39M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more...Investment focus
- Industry: E-Commerce, Life Science, Biotechnology
- Stage:Series A, Series B, Series D
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $45M–$165M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 447
- Round size: Seed $567k–$6.7M; Pre-Seed $55k–$2.9M; Series A $5.1M–$30M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- Sourcepulse — Your early warning system for software delivery (YC S23)
- EverSettled — Navigate the probate process with confidence. We provide a free checklist, guidance, and support to help families find clarity in the chaos of loss.
- Peripheral Labs — Peripheral Labs provides technology for live media and spatial intelligence.
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 225
- Round size: Seed $3M–$12M; Series A $11M–$50M; Series B $21M–$150M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $11M in 2025
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- River — Empowering people, improving lives.
- Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across Healthcare, Life Science and Electronics.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Medical
- Stage:Grant, Seed, Series A
- Geography: United States, Germany, China
Investor stats
- Total investments: 16
- Round size: Seed $25k–$4.7M; Grant $29k–$60k; Series A $25M–$84M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Proteologix — Proteologix is a precision immunology company powered by proprietary multi-specific antibody technologies. The company is dedicated to the discovery and development of safe and convenient therapeutics that target multiple disease-driving pathways to potentially deliver high-bar efficacy for patients with immune-mediated diseases.
- Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
- Ambrosia Biosciences — Drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
ALMARO Holding AG hat den Sitz in Zug. Sie ist eine Aktiengesellschaft und in der Branche «Betreiben von übrigen Finanzinstitutionen» tätig.
Show more...Investment focus
- Industry: Video Games, Life Science, Therapeutics
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Seed $1.1M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
Catalpa Venture is a seed investor based in Luxembourg
Show more...Investment focus
- Industry: Software, Information Technology, B2B
- Stage:Seed, Angel, Venture - Series Unknown
- Geography: Germany, Luxembourg, The Netherlands
Investor stats
- Total investments: 7
- Round size: Seed $1.3M–$1.4M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- Magic Horizons — Magic Horizons is building a global platform for holistic relaxation and mental health in VR, based on scientific research and a study by Humboldt-Universität zu Berlin. Magic Horizons offers a unique opportunity for relaxation and mental health in VR for every stressed out person worldwide. The result of our work at Magic Horizons are deeprelaxation states at the touch of a button.
- Mädchenflohmarkt — Mädchenflohmarkt (Meaning: Girls Fleamarket) was founded in 2012 by Peter Ambrozy, Maria Spilka and Thorsten Lückemeier. The Stuttgart-based company operates an online marketplace for used women's fashion. The platform offers not only a fashion-focused marketplace for private buyers and sellers, but also a so-called "conciergeservice". Mädchenflohmarkt offers the concierge service to users wanting to sell their goods on the platform, without listing their goods themselves. These sellers send their items to the Mädchenflohmarkt office, where they are photographed, listed and sold on the platform.Already after 4 months of operation the young start-up reached high virality through its facebook group (215k Fans) and German mass-media coverage and will continue its efforts in a social and curated shopping approach to women. A relaunch is planned for December 2012.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 95
- Round size: Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
A venture DAO supporting the Ethereum Ecosystem
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Singapore, Switzerland
Investor stats
- Total investments: 150
- Round size: Seed $1M–$8.5M; Series A $4.4M–$30M; Venture - Series Unknown $100k–$24M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Bio.xyz — Biotech's new financial layer.
- Recall Labs — Textile is building new digital experiences by focusing on user privacy, transparency, and decentralization.
- Blackbird — We believe the next great hospitality technology platform should connect restaurants and their customers directly, in meaningful and ongoing ways. Blackbird is founded by a team with a passion for restaurants and a track record of using technology to solve problems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MediVentures is an investment firm.
Show more...Investment focus
- Industry: Wellness, Health Care, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 8
- Round size: Seed $2.3M–$3.6M; Series A $4.2M–$17M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Brainjo — Brainjo is a digital health company that develops virtual reality–based applications designed to support mental health and cognitive training through immersive experiences. The company’s platform focuses on evidence-based therapies and uses gamification techniques to improve user engagement and adherence to treatment programs. Its solutions includevirtual reality training tools that combine cognitive exercises with physical activity, enabling users to train memory, coordination, and problem-solving skills within interactive environments. Brainjo is also involved in developing digital therapeutics, including applications for conditions such as ADHD, which are intended to complement traditional therapy and may be integrated into healthcare systems. The company collaborates with healthcare experts, researchers, and industry partners to translate scientific insights into practical therapeutic applications delivered through its virtual reality platform.
- XO Life — XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $236M in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — We build causal disease models to help pharmaceutical and biotech companies find promising drug targets and new indications for existing assets.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 72
- Round size: Seed $1.6M–$18M; Series A $3.9M–$17M; Series B $7.3M–$53M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $85M in 2026
Portfolio highlights
- AIRMO — AIRMO is supporting the direct emitters, decision makers and financial institutions to efficiently transition to Net-0 by monitoring their direct emissions from space. With our roots in innovation and a commitment to environmental responsibility, we aim to revolutionize GHG monitoring through advanced satellite technology, proprietary LiDARinstrument and data analytics. We exist to monitor and manage humanity's impact on Earth.
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
- Entelo Bio — Precision Medicine
Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Virtual Reality
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 383
- Round size: Seed $235k–$6.6M; Pre-Seed $100k–$3M; Venture - Series Unknown $1M–$8.9M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely actively investing — fresh fund, raised $88M in 2025
Portfolio highlights
- Claryx — The hospital immune system. Claryx detects each infection, traces how it's spreading, recommends a response, and confirms that it's gone.
- SkinBit — SkinBit is a healthtech company that develops AI-powered skin cancer detection, digital mapping, and health monitoring solutions.
- Intrinsic Power — AI-managed high-voltage power & energy unlocking 40% more capacity without costly infrastructure overhauls.
Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to build iconic businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 78
- Round size: Seed $3.5M–$21M; Series A $12M–$25M; Series B $10M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $1M in 2026
Portfolio highlights
- Antares — Factory-produced, deployable fission microreactors to provide strategic energy for mission-critical systems across Earth, space, and underseas.
- Walden Robotics — Walden Robotics is an industrial robotics company that builds and deploys general-purpose, semi-humanoid robots for manufacturing and logistics.
- Turnout — Turnout Technologies is a technology related company.
Chemovator is an incubator of chemistry businesses. It is the business incubator of BASF.
Show more...Investment focus
- Industry: Software, Manufacturing, Advanced Materials
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$3.7M; Pre-Seed $975k–$2.4M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
- Replique — Replique is an online first fully encrypted 3D printing platform that makes spare part management more sustainable to large OEMs.
- Spark e-Fuels — We build technologies for affordable, scalable and sustainable e-fuels production, to enable net-zero aviation today.
EQT is a private equity firm that invests in companies and regions where there is an industrial approach.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $50M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 40
- Round size: Seed $2.2M–$9.3M; Series A $10M–$45M; Series B $8.7M–$61M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
- Project Eaden — PROJECT EADEN combines pioneering technology and engineering expertise with an immense love for food and lust for life. For full indulgence. With zero guilt.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
1kx is a research-driven global investment firm making trust instant, open, and programmable, with 160+ investments since 2018 across DeFi, stablecoins, and onchain infrastructure.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Germany, Singapore
Investor stats
- Total investments: 183
- Round size: Seed $1.8M–$11M; Series A $5M–$28M; Venture - Series Unknown $3M–$40M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
- KOR Protocol — KOR Protocol is a decentralized intellectual property (IP) infrastructure designed to empower creators, protect rights, and enable seamless collaboration and monetization of IP assets across various industries, including music, film, TV, gaming, and art. Backed by notable entities like Animoca Brands, Republic, Niantic, Sfermion, Solana, andprominent creators such as Black Mirror, Disclosure, deadmau5, and Richie Hawtin, KOR leverages blockchain, AI, and DeFi to offer a transparent, efficient, and scalable environment for IP expansion.
- Freehand — AI Teams for Complex Spend Management
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!TechOne VC is a venture capital firm. It invests in innovative tech startups founded by visionary entrepreneurs solving global problems, to deliver superior returns for our investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 72
- Round size: Seed $115k–$2.4M; Pre-Seed $30k–$605k
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- Co-one — Co-one empowers businesses to unlock the full potential of Generative AI. We provide data-driven solutions for LLM development, including evaluation and dataset generation.
- Getmobil — Getmobil operates a smart device platform for buying and selling secondhand cellphones, laptops, and tablets. The company's platform repairs defective devices as quickly as possible offers a wide selection of device accessories, buys used electronic devices in good condition from consumers, determines the problems by passing them throughextensive tests, repairs them with an expert technical team, and resells them, allowing consumers to get a new or refurbished product at an affordable, reliable, and competitive price.
- Spiky.AI — Spiky.ai delivers real-time coaching, CRM sync, and multilingual AI insights to boost sales performance and streamline meetings.
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk. We do this by supporting the wise development of transformative technologies. Our main areas of investment focus are transformative artificial intelligence and frontier mental health technologies.Leading academics estimate a 1-in-6 chance ofhuman extinction by the year 2100, largely driven by risks from emerging technologies. And now, with the exponential growth of AI, predictions are getting worse. Our startups are part of the solution. We invest in exceptional, ethical founders who are developing transformative technologies that have the potential to impact humanity on a meaningful scale, while generating attractive returns for our LPs.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 42
- Round size: Seed $2.3M–$11M; Series A $25k–$50M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Piramidal — Piramidal offers artificial intelligence software that transforms brain activity into easy-to-understand health data to help diagnose neurological diseases.
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
We are a global technology investor, sponsoring true progress.
Show more...Investment focus
- Industry: Software, Apps, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, Canada
Investor stats
- Total investments: 30
- Round size: Seed $1.2M–$15M; Pre-Seed $1.2M–$2.6M; Series A $16M–$35M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Mabyduck — Mabyduck makes it easy to evaluate AI generated content.
- Pluto.markets — Pluto is the modern investment app for the 100m Europeans living in countries without the EUR.
- Tytan Technologies — TYTAN Technologies builds autonomous interceptors engineered for the realities of modern drone warfare.
Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 95
- Round size: Seed $2M–$9M; Series A $5M–$43M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- TrueDAO — TrueDAO is a new-generation AI-native decentralized autonomous financial infrastructure. Built on the underlying logic of DAO community co-governance, it leverages smart contracts to construct an on-chain financial system integrating AI algorithm scheduling, staking, and dynamic protection. It optimizes economic parameters and asset strategies inreal time via AI models, delivers low-volatility and sustainable value growth paths for digital assets, and pioneers an innovative paradigm of autonomous finance.
- Cryopets — Pausing biological time with cryosleep for pets
- Share — From subsea cables to last-mile networks, Share coordinates fragmented infrastructure into a single ecosystem.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 186
- Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
- Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 162
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — Empowering a sustainable digital society by enabling infrastructure where it is needed.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
hiVC is an early-stage venture capital that connects early-stage startups with winning business models to achieve global success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 20
- Round size: Seed $175k–$1.2M; Pre-Seed $200k–$660k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Kidokit — Kidokit is a child development and parent support application that promotes the growth of infants and kids from one to six years old.
- Varsapp — Varsapp is a data-driven rental and resale platform helping brands gain consumer insights, increase conversions, and reduce waste. Through its B2B2C model, brands can offer products for short-term rentals, allowing users to try before they buy.With over 200,000 users and partnerships. Varsapp enables brands to test demand, build loyalty, andmonetize refurbished or excess inventory via its newly launched Varsapp Market.Consumers rent high-quality items—especially in home appliances, electronics, and lifestyle categories—and decide whether to return or purchase.Currently active in Turkey and expanding into Eastern Europe and Central Asia, Varsapp supports circular consumption while generating measurable impact for both brands and users.
- VRLab Academy — VRLab Academy | Virtual Experiments
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Seed $2M–$2.4M; Series A $5.7M–$17M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- keleya — Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany.
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.5M–$1.5M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health develops digital health application to support treatment for patients and therapists alike.
Investitionsbank Berlin (IBB) is the subsidy bank of the Federal Land of Berlin. With its newly orientated economic support and subsidy policy, it actively contributes towards developing Berlin as a business and industry location.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Grant, Seed, Series A
- Geography: Germany, Canada
Investor stats
- Total investments: 59
- Round size: Seed $566k–$2.4M; Grant $18k–$1.4M; Series A $2.2M–$19M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Quantune — A new Foundation for Human Health.
- Level Nine — Level Nine specializes in bio-nanotechnology and quantum chemistry, developing next-generation catalysts known as nanozymes.
- muffintech — Generative AI for the insurance industry. Unleash the full potential of your employees and offer your customers an unmatched user experience.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Signature Ventures is an early-stage Venture Capital fund investing in Blockchain, Distributed Ledger Technology and Web3 technology. The fund backs exceptional founders that build the backbone of the next-generation internet: open, secure, and privacy-centered. Founded in 2019, Signature is based in Germany and invests in Pre-Seed to Series Astartups globally with a focus on Europe. The company is headed by Juliane Hahn, Founding Partner, and Dr. Georg Stricker, Tech Partner. Both combine an extensive track record of VC investments with deep Blockchain expertise. Signature's diverse team follows a first principle approach and collaborates closely with an extensive ecosystem of key Blockchain industry players, VCs, corporates, and academia. With their deep expertise in tech, company building and legal matters, Signature is empowering the pioneers that are driving the paradigm shift and shape the decentralized future.
Show more...Investment focus
- Industry: Blockchain, Software, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $1.5M–$4.5M; Pre-Seed $385k–$1M; Series A $10M–$23M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- UnblockPay —
- Credit Coop — Earn through curated credit vaults backed by vetted borrowers, transparent on-chain repayments and programmable collateral. Lend to real businesses with Credit Coop.
- Gataca — Gataca is a cybersecurity company that provides decentralized digital identity technology, also known as self-sovereign identity (SSI).
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 329
- Round size: Series A $3.9M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.7M–$65M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
ATHOS Service GmbH is the family office of Thomas und Andreas Strüngmann. ATHOS Service GmbH is based in Munich, Germany.
Show more...Investment focus
- Industry: Railroad, Software, Biopharma
- Stage:Series A, Series C
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KONUX — KONUX combines Machine Learning algorithms and IoT to deliver software-as-a-service solutions for operation, monitoring, and maintenance process automation
- BioNTech — BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates.
Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series C, Series B, Post-IPO Equity
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 198
- Round size: Series B $45M–$155M; Series C $35M–$200M; Post-IPO Equity $25M–$275M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $675M in 2019
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Bios Life — Bios Life is a technology-enabled healthcare company built to empower individuals to proactively manage their cancer risk, redefining personalized cancer screening and survivorship.
- Obsidian Therapeutics — Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer.The company's next-generation cell and gene therapies with pharmacologic operating systems provide exquisite control of protein activity in cells and create adoptive cell therapies with newfunctions that are under control of the treating physician using simple, safe, orally-active, marketed drugs, enabling patients to improve on the current generation of cell therapies.
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more...Investment focus
- Industry: Social Media, News, Apps
- Stage:Seed, Angel, Convertible Note
- Geography: Germany, France, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Krak — Make more skateboarding happen in the world.
- HashtagNow — HashtagNow is the real-time news platform that uses hashtags to discover and provide context for topics people talk about across platforms.
- Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Firegroup Holding AG is a Swiss holding company.
Show more...Investment focus
- Industry: Video Games, Life Science, Therapeutics
- Stage:Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
Kindergarten Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Germany
Investor stats
- Total investments: 18
- Lead/follow: no public data
Portfolio highlights
- RLcore — Reimagining intelligent control with reinforcement learning. Shaping the future of industrial control with real-time autonomous optimization.
- StretchDollar — The simplest, most affordable health benefit option for small businesses. More control over your budget and more choice for your people. Get started today!
- ThreeV Technologies, Inc. — End to End Inspection Lifecycle Management Platform using AI
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 277
- Lead/follow: no public data
Portfolio highlights
- Vega — The comprehensive wealth creation platform for high-net-worth individuals and their advisors. Vega bridges the gap between the institutional and private wealth management worlds.
- Aleph — Aleph helps top finance teams work with their data in real time. Businesses can automate financial models and streamline budgeting and forecasting with the fastest-to-implement FP&A platform. Aleph eliminates the need to export data from multiple sources by syncing spreadsheet models with data from 150+ integrations, and allows teams tointeract with their data in no-code dashboards.From annual budgeting to ad hoc reporting, scale your financial processes faster with better data without expanding your team. See why over 90% of people who start a trial with Aleph become customers!
- Flawless — Use Flawless to real-time monitor your operational data and quickly identify & resolve incidents. Start in just 5 minutes, no coding required.
We are futurists, cross-boundary problem solvers and cultural anthropologists.
Show more...Investment focus
- Industry: FinTech, Financial Services, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, China, Brazil
Investor stats
- Total investments: 57
- Lead/follow: no public data
Portfolio highlights
- Ualá — Ualá is a fintech company whose mission is to bring Latin American financial services into the 21st century. Through an app and an international Mastercard card, it offers an innovative and integrated experience. It also brings the unbanked into the financial system by offering cheaper and more convenient services than any other alternative.Itwas founded by the Argentine entrepreneur Pierpaolo Barbieri and launched in October 2017 in Argentina and in September 2020 in Mexico.Ualá offers an international Mastercard card and is the first free card on the market, with no issuance, renewal, maintenance, and closing costs. It can be used to make purchases on any website or store in the world that accepts Mastercard. In addition, it offers the possibility of carrying out a wide variety of financial transactions through the app such as transferring money, paying bills, and topping up cell phones and transportation cards. Users can also track expenses through an analysis tool, apply for loans and invest in mutual funds.With more than 3.100 million cards issued, it is available throughout Argentina for anyone above 13 and Mexico for anyone above 18, both for Android and iOS.
- SadaPay — Sign up today to get your Mastercard debit card and digital wallet. Easily request funds, top up mobile balance, manage remittances and more through our easy-to-use app!
- Metatheory — Metatheory Inc. is an interactive technology and entertainment company building Web3 games, interactive content, social experiences, and other community-driven adventures. Metatheory’s mission is to inspire imagination by connecting people worldwide through immersive worlds built on cross-generational IP.
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- PL BioScience — Animal-free cell culture supplements derived from human platelets. Supporting cell expansion and maintenance from research to therapy.
- Black Semiconductor — Black Semiconductor manufacture microchips with integrated electronic-photonic circuits using graphene technology.
Life Science VC funding in Germany at a glance
Stats across 170 deals from 278 investors.
Access all 278 VC funds in Germany Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 278 VC funds investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!